Mutational landscape of homologous recombination‐related genes in small‐cell lung cancer

BACKGROUND: Homologous recombination deficiency (HRD) is a well‐known biomarker which could predict poly‐ADP ribose polymerase 1 (PARP) inhibitor and platinum drug response. As an aggressive cancer, small‐cell lung cancer (SCLC) is sensitive to platinum drugs, but relapse occurs rapidly. Herein, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shuo, Zhang, Yao, Zhang, Yan, Chen, Liz‐han, Ouyang, Hai‐feng, Xu, Xi, Du, Ying, Ti, Xin‐yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972032/
https://www.ncbi.nlm.nih.gov/pubmed/36053931
http://dx.doi.org/10.1002/cam4.5148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972032/
https://www.ncbi.nlm.nih.gov/pubmed/36053931
http://dx.doi.org/10.1002/cam4.5148

Ejemplares similares